Short Interest in Carmell Co. (NASDAQ:CTCX) Decreases By 11.4%

Carmell Co. (NASDAQ:CTCX) was the target of a large drop in short interest in September. As of September 30th, there was short interest totalling 36,600 shares, a drop of 11.4% from the September 15th total of 41,300 shares. Approximately 0.3% of the company’s stock are sold short. Based on an average daily volume of 660,300 shares, the days-to-cover ratio is currently 0.1 days.

Institutional Investors Weigh In On Carmell

An institutional investor recently bought a new position in Carmell stock. Warberg Asset Management LLC acquired a new position in shares of Carmell Co. (NASDAQ:CTCX) during the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm acquired 45,000 shares of the company’s stock, valued at approximately $60,000. Warberg Asset Management LLC owned approximately 0.22% of Carmell at the end of the most recent quarter. Institutional investors own 24.22% of the company’s stock.

Carmell Price Performance

Shares of Carmell stock traded up $0.00 during trading on Tuesday, hitting $0.35. 171,955 shares of the stock were exchanged, compared to its average volume of 242,217. The firm’s 50-day moving average price is $0.58 and its 200 day moving average price is $1.47. Carmell has a 12-month low of $0.29 and a 12-month high of $4.31.

Carmell (NASDAQ:CTCX) last announced its quarterly earnings results on Wednesday, August 14th. The company reported ($0.16) earnings per share (EPS) for the quarter. The business had revenue of $0.01 million during the quarter.

About Carmell

Carmell Corporation operates as a bio-aesthetics company. The company utilizes Carmell Secretome to support skin and hair health. Its Carmell Secretome consists of growth factors and proteins extracted from allogeneic human platelets sourced from tissue banks. The company also developed a microemulsion formulation that enables delivery of lipophilic and hydrophilic ingredients without relying on the Foul Fourteen, 14 potentially harmful excipients that are commonly used by other companies to impart texture, stability, and other desirable physicochemical attributes to cosmetic products.